BMC PULM MED 润色咨询

BMC Pulmonary Medicine

出版年份：暂无数据 年文章数：2458 投稿命中率： 开通期刊会员，数据随心看

出版周期：Irregular 自引率：2.8% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2206072, encodeId=a71b22060e24d, content=审稿速度:12.0 | 投稿命中率:75.0<br>偏重的研究方向：呼吸科<br>经验分享：投稿九个月没意见，无奈了，催了好多次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/09/90c43e208f90c98f3386f19b2dc3d3b7.jpg, createdBy=a1962178299, createdName=爱爬树的松鼠, createdTime=Wed May 22 19:10:42 CST 2024, time=17小时前, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090674, encodeId=461e20906e471, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：肺疾病;肿瘤;肺肿瘤<br>经验分享：6.12 First submitted 6.15 Editor invited 6.25 Reviewers invited 7.3 Reviews received 8.9 Major revision 8.19 Submitted 9.8 Reviewers invited 9.20 Major revision 9.27 Accepted 三个月时间，大修了两次，因为条件原因无法补实验，但是最终还是接收了，编辑真的很不错！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80638145994, createdName=ms6000001354647172, createdTime=Tue Sep 27 18:27:07 CST 2022, time=2022-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167979, encodeId=d3e1216e979a7, content=Editor Invited 已经一个多月了啊，怎么搞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e486569012, createdName=ms8000000465818220, createdTime=Sat Nov 11 15:02:18 CST 2023, time=2023-11-11, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2140538, encodeId=b41c21405383f, content=质量检查快一个月了，只有我是这样吗，哭死, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c558548408, createdName=ms5000001956621569, createdTime=Fri Jun 02 21:43:26 CST 2023, time=2023-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170591, encodeId=e64321e059198, content=审稿速度:6.0<br>偏重的研究方向：呼吸科;队列研究;临床<br>经验分享：速度偏慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/CPZXS1oic8FNDveZPW5MibyMJSdA1refksJRlAvOE7yHvVpVq5qlsPeHJVZDn0s8Xe1FcZAnqAwBkibf2GzHmrib4g/132, createdBy=3d292264400, createdName=hstb, createdTime=Thu Nov 23 20:28:04 CST 2023, time=2023-11-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2166518, encodeId=88322166518d8, content=审稿速度:4.0 | 投稿命中率:75.0<br>偏重的研究方向：肺肿瘤<br>经验分享：省了半年 前面一直找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1468375409, createdName=ms2000001878750293, createdTime=Fri Nov 03 16:21:43 CST 2023, time=2023-11-03, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2159829, encodeId=61162159829a0, content=ss, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=de4b5235057, createdName=147ab6f6m58(暂无昵称), createdTime=Tue Sep 26 16:07:47 CST 2023, time=2023-09-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2157853, encodeId=6391215e85305, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：呼吸科<br>经验分享：2023年4.21投稿，6.16大修，7.12修回，8.11小修，9.8录用，9.13 proof 现在正在交版面费阶段, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1efa8537263, createdName=ms3000000776207476, createdTime=Fri Sep 15 16:10:20 CST 2023, time=2023-09-15, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2123633, encodeId=682e212363326, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：肺癌<br>经验分享：2022年10月15日转投，1月8号大修，然后1月29修回，3月22小修（格式问题），3月23修回，4月3accept。总体速度可以，一审时间有点久，当初发邮件给编辑部问了一下。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08cd5169632, createdName=146d3b97m12(暂无昵称), createdTime=Tue Apr 04 10:28:17 CST 2023, time=2023-04-04, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2139285, encodeId=7c8b21392850b, content=审稿速度:1.0<br>偏重的研究方向：队列研究;肺结核<br>经验分享：想问下有最近接收的嘛？现在显示Peer review, Editor Invited 两个状态??是还没有编辑愿意接手嘛？这个状态一般要持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc885635200, createdName=ms5000001401005050, createdTime=Fri May 26 21:25:04 CST 2023, time=2023-05-26, status=1, ipAttribution=山东省)]
    17小时前 爱爬树的松鼠

    审稿速度:12.0 | 投稿命中率:75.0
    偏重的研究方向：呼吸科
    经验分享：投稿九个月没意见，无奈了，催了好多次

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2206072, encodeId=a71b22060e24d, content=审稿速度:12.0 | 投稿命中率:75.0<br>偏重的研究方向：呼吸科<br>经验分享：投稿九个月没意见，无奈了，催了好多次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/09/90c43e208f90c98f3386f19b2dc3d3b7.jpg, createdBy=a1962178299, createdName=爱爬树的松鼠, createdTime=Wed May 22 19:10:42 CST 2024, time=17小时前, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090674, encodeId=461e20906e471, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：肺疾病;肿瘤;肺肿瘤<br>经验分享：6.12 First submitted 6.15 Editor invited 6.25 Reviewers invited 7.3 Reviews received 8.9 Major revision 8.19 Submitted 9.8 Reviewers invited 9.20 Major revision 9.27 Accepted 三个月时间，大修了两次，因为条件原因无法补实验，但是最终还是接收了，编辑真的很不错！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80638145994, createdName=ms6000001354647172, createdTime=Tue Sep 27 18:27:07 CST 2022, time=2022-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167979, encodeId=d3e1216e979a7, content=Editor Invited 已经一个多月了啊，怎么搞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e486569012, createdName=ms8000000465818220, createdTime=Sat Nov 11 15:02:18 CST 2023, time=2023-11-11, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2140538, encodeId=b41c21405383f, content=质量检查快一个月了，只有我是这样吗，哭死, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c558548408, createdName=ms5000001956621569, createdTime=Fri Jun 02 21:43:26 CST 2023, time=2023-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170591, encodeId=e64321e059198, content=审稿速度:6.0<br>偏重的研究方向：呼吸科;队列研究;临床<br>经验分享：速度偏慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/CPZXS1oic8FNDveZPW5MibyMJSdA1refksJRlAvOE7yHvVpVq5qlsPeHJVZDn0s8Xe1FcZAnqAwBkibf2GzHmrib4g/132, createdBy=3d292264400, createdName=hstb, createdTime=Thu Nov 23 20:28:04 CST 2023, time=2023-11-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2166518, encodeId=88322166518d8, content=审稿速度:4.0 | 投稿命中率:75.0<br>偏重的研究方向：肺肿瘤<br>经验分享：省了半年 前面一直找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1468375409, createdName=ms2000001878750293, createdTime=Fri Nov 03 16:21:43 CST 2023, time=2023-11-03, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2159829, encodeId=61162159829a0, content=ss, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=de4b5235057, createdName=147ab6f6m58(暂无昵称), createdTime=Tue Sep 26 16:07:47 CST 2023, time=2023-09-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2157853, encodeId=6391215e85305, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：呼吸科<br>经验分享：2023年4.21投稿，6.16大修，7.12修回，8.11小修，9.8录用，9.13 proof 现在正在交版面费阶段, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1efa8537263, createdName=ms3000000776207476, createdTime=Fri Sep 15 16:10:20 CST 2023, time=2023-09-15, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2123633, encodeId=682e212363326, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：肺癌<br>经验分享：2022年10月15日转投，1月8号大修，然后1月29修回，3月22小修（格式问题），3月23修回，4月3accept。总体速度可以，一审时间有点久，当初发邮件给编辑部问了一下。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08cd5169632, createdName=146d3b97m12(暂无昵称), createdTime=Tue Apr 04 10:28:17 CST 2023, time=2023-04-04, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2139285, encodeId=7c8b21392850b, content=审稿速度:1.0<br>偏重的研究方向：队列研究;肺结核<br>经验分享：想问下有最近接收的嘛？现在显示Peer review, Editor Invited 两个状态??是还没有编辑愿意接手嘛？这个状态一般要持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc885635200, createdName=ms5000001401005050, createdTime=Fri May 26 21:25:04 CST 2023, time=2023-05-26, status=1, ipAttribution=山东省)]
    2022-09-27 ms6000001354647172

    审稿速度:3.0 | 投稿命中率:50.0
    偏重的研究方向：肺疾病;肿瘤;肺肿瘤
    经验分享：6.12 First submitted 6.15 Editor invited 6.25 Reviewers invited 7.3 Reviews received 8.9 Major revision 8.19 Submitted 9.8 Reviewers invited 9.20 Major revision 9.27 Accepted 三个月时间，大修了两次，因为条件原因无法补实验，但是最终还是接收了，编辑真的很不错！

    7

    展开7条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2206072, encodeId=a71b22060e24d, content=审稿速度:12.0 | 投稿命中率:75.0<br>偏重的研究方向：呼吸科<br>经验分享：投稿九个月没意见，无奈了，催了好多次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/09/90c43e208f90c98f3386f19b2dc3d3b7.jpg, createdBy=a1962178299, createdName=爱爬树的松鼠, createdTime=Wed May 22 19:10:42 CST 2024, time=17小时前, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090674, encodeId=461e20906e471, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：肺疾病;肿瘤;肺肿瘤<br>经验分享：6.12 First submitted 6.15 Editor invited 6.25 Reviewers invited 7.3 Reviews received 8.9 Major revision 8.19 Submitted 9.8 Reviewers invited 9.20 Major revision 9.27 Accepted 三个月时间，大修了两次，因为条件原因无法补实验，但是最终还是接收了，编辑真的很不错！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80638145994, createdName=ms6000001354647172, createdTime=Tue Sep 27 18:27:07 CST 2022, time=2022-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167979, encodeId=d3e1216e979a7, content=Editor Invited 已经一个多月了啊，怎么搞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e486569012, createdName=ms8000000465818220, createdTime=Sat Nov 11 15:02:18 CST 2023, time=2023-11-11, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2140538, encodeId=b41c21405383f, content=质量检查快一个月了，只有我是这样吗，哭死, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c558548408, createdName=ms5000001956621569, createdTime=Fri Jun 02 21:43:26 CST 2023, time=2023-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170591, encodeId=e64321e059198, content=审稿速度:6.0<br>偏重的研究方向：呼吸科;队列研究;临床<br>经验分享：速度偏慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/CPZXS1oic8FNDveZPW5MibyMJSdA1refksJRlAvOE7yHvVpVq5qlsPeHJVZDn0s8Xe1FcZAnqAwBkibf2GzHmrib4g/132, createdBy=3d292264400, createdName=hstb, createdTime=Thu Nov 23 20:28:04 CST 2023, time=2023-11-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2166518, encodeId=88322166518d8, content=审稿速度:4.0 | 投稿命中率:75.0<br>偏重的研究方向：肺肿瘤<br>经验分享：省了半年 前面一直找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1468375409, createdName=ms2000001878750293, createdTime=Fri Nov 03 16:21:43 CST 2023, time=2023-11-03, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2159829, encodeId=61162159829a0, content=ss, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=de4b5235057, createdName=147ab6f6m58(暂无昵称), createdTime=Tue Sep 26 16:07:47 CST 2023, time=2023-09-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2157853, encodeId=6391215e85305, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：呼吸科<br>经验分享：2023年4.21投稿，6.16大修，7.12修回，8.11小修，9.8录用，9.13 proof 现在正在交版面费阶段, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1efa8537263, createdName=ms3000000776207476, createdTime=Fri Sep 15 16:10:20 CST 2023, time=2023-09-15, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2123633, encodeId=682e212363326, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：肺癌<br>经验分享：2022年10月15日转投，1月8号大修，然后1月29修回，3月22小修（格式问题），3月23修回，4月3accept。总体速度可以，一审时间有点久，当初发邮件给编辑部问了一下。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08cd5169632, createdName=146d3b97m12(暂无昵称), createdTime=Tue Apr 04 10:28:17 CST 2023, time=2023-04-04, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2139285, encodeId=7c8b21392850b, content=审稿速度:1.0<br>偏重的研究方向：队列研究;肺结核<br>经验分享：想问下有最近接收的嘛？现在显示Peer review, Editor Invited 两个状态??是还没有编辑愿意接手嘛？这个状态一般要持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc885635200, createdName=ms5000001401005050, createdTime=Fri May 26 21:25:04 CST 2023, time=2023-05-26, status=1, ipAttribution=山东省)]
    2023-11-11 ms8000000465818220 来自安徽省

    Editor Invited 已经一个多月了啊，怎么搞

    4

    展开4条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2206072, encodeId=a71b22060e24d, content=审稿速度:12.0 | 投稿命中率:75.0<br>偏重的研究方向：呼吸科<br>经验分享：投稿九个月没意见，无奈了，催了好多次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/09/90c43e208f90c98f3386f19b2dc3d3b7.jpg, createdBy=a1962178299, createdName=爱爬树的松鼠, createdTime=Wed May 22 19:10:42 CST 2024, time=17小时前, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090674, encodeId=461e20906e471, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：肺疾病;肿瘤;肺肿瘤<br>经验分享：6.12 First submitted 6.15 Editor invited 6.25 Reviewers invited 7.3 Reviews received 8.9 Major revision 8.19 Submitted 9.8 Reviewers invited 9.20 Major revision 9.27 Accepted 三个月时间，大修了两次，因为条件原因无法补实验，但是最终还是接收了，编辑真的很不错！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80638145994, createdName=ms6000001354647172, createdTime=Tue Sep 27 18:27:07 CST 2022, time=2022-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167979, encodeId=d3e1216e979a7, content=Editor Invited 已经一个多月了啊，怎么搞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e486569012, createdName=ms8000000465818220, createdTime=Sat Nov 11 15:02:18 CST 2023, time=2023-11-11, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2140538, encodeId=b41c21405383f, content=质量检查快一个月了，只有我是这样吗，哭死, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c558548408, createdName=ms5000001956621569, createdTime=Fri Jun 02 21:43:26 CST 2023, time=2023-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170591, encodeId=e64321e059198, content=审稿速度:6.0<br>偏重的研究方向：呼吸科;队列研究;临床<br>经验分享：速度偏慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/CPZXS1oic8FNDveZPW5MibyMJSdA1refksJRlAvOE7yHvVpVq5qlsPeHJVZDn0s8Xe1FcZAnqAwBkibf2GzHmrib4g/132, createdBy=3d292264400, createdName=hstb, createdTime=Thu Nov 23 20:28:04 CST 2023, time=2023-11-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2166518, encodeId=88322166518d8, content=审稿速度:4.0 | 投稿命中率:75.0<br>偏重的研究方向：肺肿瘤<br>经验分享：省了半年 前面一直找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1468375409, createdName=ms2000001878750293, createdTime=Fri Nov 03 16:21:43 CST 2023, time=2023-11-03, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2159829, encodeId=61162159829a0, content=ss, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=de4b5235057, createdName=147ab6f6m58(暂无昵称), createdTime=Tue Sep 26 16:07:47 CST 2023, time=2023-09-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2157853, encodeId=6391215e85305, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：呼吸科<br>经验分享：2023年4.21投稿，6.16大修，7.12修回，8.11小修，9.8录用，9.13 proof 现在正在交版面费阶段, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1efa8537263, createdName=ms3000000776207476, createdTime=Fri Sep 15 16:10:20 CST 2023, time=2023-09-15, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2123633, encodeId=682e212363326, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：肺癌<br>经验分享：2022年10月15日转投，1月8号大修，然后1月29修回，3月22小修（格式问题），3月23修回，4月3accept。总体速度可以，一审时间有点久，当初发邮件给编辑部问了一下。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08cd5169632, createdName=146d3b97m12(暂无昵称), createdTime=Tue Apr 04 10:28:17 CST 2023, time=2023-04-04, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2139285, encodeId=7c8b21392850b, content=审稿速度:1.0<br>偏重的研究方向：队列研究;肺结核<br>经验分享：想问下有最近接收的嘛？现在显示Peer review, Editor Invited 两个状态??是还没有编辑愿意接手嘛？这个状态一般要持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc885635200, createdName=ms5000001401005050, createdTime=Fri May 26 21:25:04 CST 2023, time=2023-05-26, status=1, ipAttribution=山东省)]
    2023-06-02 ms5000001956621569

    质量检查快一个月了，只有我是这样吗，哭死

    3

    展开3条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2206072, encodeId=a71b22060e24d, content=审稿速度:12.0 | 投稿命中率:75.0<br>偏重的研究方向：呼吸科<br>经验分享：投稿九个月没意见，无奈了，催了好多次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/09/90c43e208f90c98f3386f19b2dc3d3b7.jpg, createdBy=a1962178299, createdName=爱爬树的松鼠, createdTime=Wed May 22 19:10:42 CST 2024, time=17小时前, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090674, encodeId=461e20906e471, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：肺疾病;肿瘤;肺肿瘤<br>经验分享：6.12 First submitted 6.15 Editor invited 6.25 Reviewers invited 7.3 Reviews received 8.9 Major revision 8.19 Submitted 9.8 Reviewers invited 9.20 Major revision 9.27 Accepted 三个月时间，大修了两次，因为条件原因无法补实验，但是最终还是接收了，编辑真的很不错！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80638145994, createdName=ms6000001354647172, createdTime=Tue Sep 27 18:27:07 CST 2022, time=2022-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167979, encodeId=d3e1216e979a7, content=Editor Invited 已经一个多月了啊，怎么搞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e486569012, createdName=ms8000000465818220, createdTime=Sat Nov 11 15:02:18 CST 2023, time=2023-11-11, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2140538, encodeId=b41c21405383f, content=质量检查快一个月了，只有我是这样吗，哭死, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c558548408, createdName=ms5000001956621569, createdTime=Fri Jun 02 21:43:26 CST 2023, time=2023-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170591, encodeId=e64321e059198, content=审稿速度:6.0<br>偏重的研究方向：呼吸科;队列研究;临床<br>经验分享：速度偏慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/CPZXS1oic8FNDveZPW5MibyMJSdA1refksJRlAvOE7yHvVpVq5qlsPeHJVZDn0s8Xe1FcZAnqAwBkibf2GzHmrib4g/132, createdBy=3d292264400, createdName=hstb, createdTime=Thu Nov 23 20:28:04 CST 2023, time=2023-11-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2166518, encodeId=88322166518d8, content=审稿速度:4.0 | 投稿命中率:75.0<br>偏重的研究方向：肺肿瘤<br>经验分享：省了半年 前面一直找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1468375409, createdName=ms2000001878750293, createdTime=Fri Nov 03 16:21:43 CST 2023, time=2023-11-03, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2159829, encodeId=61162159829a0, content=ss, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=de4b5235057, createdName=147ab6f6m58(暂无昵称), createdTime=Tue Sep 26 16:07:47 CST 2023, time=2023-09-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2157853, encodeId=6391215e85305, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：呼吸科<br>经验分享：2023年4.21投稿，6.16大修，7.12修回，8.11小修，9.8录用，9.13 proof 现在正在交版面费阶段, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1efa8537263, createdName=ms3000000776207476, createdTime=Fri Sep 15 16:10:20 CST 2023, time=2023-09-15, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2123633, encodeId=682e212363326, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：肺癌<br>经验分享：2022年10月15日转投，1月8号大修，然后1月29修回，3月22小修（格式问题），3月23修回，4月3accept。总体速度可以，一审时间有点久，当初发邮件给编辑部问了一下。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08cd5169632, createdName=146d3b97m12(暂无昵称), createdTime=Tue Apr 04 10:28:17 CST 2023, time=2023-04-04, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2139285, encodeId=7c8b21392850b, content=审稿速度:1.0<br>偏重的研究方向：队列研究;肺结核<br>经验分享：想问下有最近接收的嘛？现在显示Peer review, Editor Invited 两个状态??是还没有编辑愿意接手嘛？这个状态一般要持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc885635200, createdName=ms5000001401005050, createdTime=Fri May 26 21:25:04 CST 2023, time=2023-05-26, status=1, ipAttribution=山东省)]
    2023-11-23 hstb 来自北京

    审稿速度:6.0
    偏重的研究方向：呼吸科;队列研究;临床
    经验分享：速度偏慢

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2206072, encodeId=a71b22060e24d, content=审稿速度:12.0 | 投稿命中率:75.0<br>偏重的研究方向：呼吸科<br>经验分享：投稿九个月没意见，无奈了，催了好多次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/09/90c43e208f90c98f3386f19b2dc3d3b7.jpg, createdBy=a1962178299, createdName=爱爬树的松鼠, createdTime=Wed May 22 19:10:42 CST 2024, time=17小时前, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090674, encodeId=461e20906e471, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：肺疾病;肿瘤;肺肿瘤<br>经验分享：6.12 First submitted 6.15 Editor invited 6.25 Reviewers invited 7.3 Reviews received 8.9 Major revision 8.19 Submitted 9.8 Reviewers invited 9.20 Major revision 9.27 Accepted 三个月时间，大修了两次，因为条件原因无法补实验，但是最终还是接收了，编辑真的很不错！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80638145994, createdName=ms6000001354647172, createdTime=Tue Sep 27 18:27:07 CST 2022, time=2022-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167979, encodeId=d3e1216e979a7, content=Editor Invited 已经一个多月了啊，怎么搞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e486569012, createdName=ms8000000465818220, createdTime=Sat Nov 11 15:02:18 CST 2023, time=2023-11-11, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2140538, encodeId=b41c21405383f, content=质量检查快一个月了，只有我是这样吗，哭死, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c558548408, createdName=ms5000001956621569, createdTime=Fri Jun 02 21:43:26 CST 2023, time=2023-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170591, encodeId=e64321e059198, content=审稿速度:6.0<br>偏重的研究方向：呼吸科;队列研究;临床<br>经验分享：速度偏慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/CPZXS1oic8FNDveZPW5MibyMJSdA1refksJRlAvOE7yHvVpVq5qlsPeHJVZDn0s8Xe1FcZAnqAwBkibf2GzHmrib4g/132, createdBy=3d292264400, createdName=hstb, createdTime=Thu Nov 23 20:28:04 CST 2023, time=2023-11-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2166518, encodeId=88322166518d8, content=审稿速度:4.0 | 投稿命中率:75.0<br>偏重的研究方向：肺肿瘤<br>经验分享：省了半年 前面一直找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1468375409, createdName=ms2000001878750293, createdTime=Fri Nov 03 16:21:43 CST 2023, time=2023-11-03, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2159829, encodeId=61162159829a0, content=ss, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=de4b5235057, createdName=147ab6f6m58(暂无昵称), createdTime=Tue Sep 26 16:07:47 CST 2023, time=2023-09-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2157853, encodeId=6391215e85305, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：呼吸科<br>经验分享：2023年4.21投稿，6.16大修，7.12修回，8.11小修，9.8录用，9.13 proof 现在正在交版面费阶段, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1efa8537263, createdName=ms3000000776207476, createdTime=Fri Sep 15 16:10:20 CST 2023, time=2023-09-15, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2123633, encodeId=682e212363326, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：肺癌<br>经验分享：2022年10月15日转投，1月8号大修，然后1月29修回，3月22小修（格式问题），3月23修回，4月3accept。总体速度可以，一审时间有点久，当初发邮件给编辑部问了一下。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08cd5169632, createdName=146d3b97m12(暂无昵称), createdTime=Tue Apr 04 10:28:17 CST 2023, time=2023-04-04, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2139285, encodeId=7c8b21392850b, content=审稿速度:1.0<br>偏重的研究方向：队列研究;肺结核<br>经验分享：想问下有最近接收的嘛？现在显示Peer review, Editor Invited 两个状态??是还没有编辑愿意接手嘛？这个状态一般要持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc885635200, createdName=ms5000001401005050, createdTime=Fri May 26 21:25:04 CST 2023, time=2023-05-26, status=1, ipAttribution=山东省)]
    2023-11-03 ms2000001878750293 来自宁夏

    审稿速度:4.0 | 投稿命中率:75.0
    偏重的研究方向：肺肿瘤
    经验分享：省了半年 前面一直找不到审稿人

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2206072, encodeId=a71b22060e24d, content=审稿速度:12.0 | 投稿命中率:75.0<br>偏重的研究方向：呼吸科<br>经验分享：投稿九个月没意见，无奈了，催了好多次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/09/90c43e208f90c98f3386f19b2dc3d3b7.jpg, createdBy=a1962178299, createdName=爱爬树的松鼠, createdTime=Wed May 22 19:10:42 CST 2024, time=17小时前, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090674, encodeId=461e20906e471, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：肺疾病;肿瘤;肺肿瘤<br>经验分享：6.12 First submitted 6.15 Editor invited 6.25 Reviewers invited 7.3 Reviews received 8.9 Major revision 8.19 Submitted 9.8 Reviewers invited 9.20 Major revision 9.27 Accepted 三个月时间，大修了两次，因为条件原因无法补实验，但是最终还是接收了，编辑真的很不错！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80638145994, createdName=ms6000001354647172, createdTime=Tue Sep 27 18:27:07 CST 2022, time=2022-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167979, encodeId=d3e1216e979a7, content=Editor Invited 已经一个多月了啊，怎么搞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e486569012, createdName=ms8000000465818220, createdTime=Sat Nov 11 15:02:18 CST 2023, time=2023-11-11, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2140538, encodeId=b41c21405383f, content=质量检查快一个月了，只有我是这样吗，哭死, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c558548408, createdName=ms5000001956621569, createdTime=Fri Jun 02 21:43:26 CST 2023, time=2023-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170591, encodeId=e64321e059198, content=审稿速度:6.0<br>偏重的研究方向：呼吸科;队列研究;临床<br>经验分享：速度偏慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/CPZXS1oic8FNDveZPW5MibyMJSdA1refksJRlAvOE7yHvVpVq5qlsPeHJVZDn0s8Xe1FcZAnqAwBkibf2GzHmrib4g/132, createdBy=3d292264400, createdName=hstb, createdTime=Thu Nov 23 20:28:04 CST 2023, time=2023-11-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2166518, encodeId=88322166518d8, content=审稿速度:4.0 | 投稿命中率:75.0<br>偏重的研究方向：肺肿瘤<br>经验分享：省了半年 前面一直找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1468375409, createdName=ms2000001878750293, createdTime=Fri Nov 03 16:21:43 CST 2023, time=2023-11-03, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2159829, encodeId=61162159829a0, content=ss, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=de4b5235057, createdName=147ab6f6m58(暂无昵称), createdTime=Tue Sep 26 16:07:47 CST 2023, time=2023-09-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2157853, encodeId=6391215e85305, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：呼吸科<br>经验分享：2023年4.21投稿，6.16大修，7.12修回，8.11小修，9.8录用，9.13 proof 现在正在交版面费阶段, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1efa8537263, createdName=ms3000000776207476, createdTime=Fri Sep 15 16:10:20 CST 2023, time=2023-09-15, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2123633, encodeId=682e212363326, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：肺癌<br>经验分享：2022年10月15日转投，1月8号大修，然后1月29修回，3月22小修（格式问题），3月23修回，4月3accept。总体速度可以，一审时间有点久，当初发邮件给编辑部问了一下。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08cd5169632, createdName=146d3b97m12(暂无昵称), createdTime=Tue Apr 04 10:28:17 CST 2023, time=2023-04-04, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2139285, encodeId=7c8b21392850b, content=审稿速度:1.0<br>偏重的研究方向：队列研究;肺结核<br>经验分享：想问下有最近接收的嘛？现在显示Peer review, Editor Invited 两个状态??是还没有编辑愿意接手嘛？这个状态一般要持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc885635200, createdName=ms5000001401005050, createdTime=Fri May 26 21:25:04 CST 2023, time=2023-05-26, status=1, ipAttribution=山东省)]
    2023-09-26 147ab6f6m58(暂无昵称) 来自浙江省

    ss

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2206072, encodeId=a71b22060e24d, content=审稿速度:12.0 | 投稿命中率:75.0<br>偏重的研究方向：呼吸科<br>经验分享：投稿九个月没意见，无奈了，催了好多次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/09/90c43e208f90c98f3386f19b2dc3d3b7.jpg, createdBy=a1962178299, createdName=爱爬树的松鼠, createdTime=Wed May 22 19:10:42 CST 2024, time=17小时前, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090674, encodeId=461e20906e471, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：肺疾病;肿瘤;肺肿瘤<br>经验分享：6.12 First submitted 6.15 Editor invited 6.25 Reviewers invited 7.3 Reviews received 8.9 Major revision 8.19 Submitted 9.8 Reviewers invited 9.20 Major revision 9.27 Accepted 三个月时间，大修了两次，因为条件原因无法补实验，但是最终还是接收了，编辑真的很不错！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80638145994, createdName=ms6000001354647172, createdTime=Tue Sep 27 18:27:07 CST 2022, time=2022-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167979, encodeId=d3e1216e979a7, content=Editor Invited 已经一个多月了啊，怎么搞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e486569012, createdName=ms8000000465818220, createdTime=Sat Nov 11 15:02:18 CST 2023, time=2023-11-11, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2140538, encodeId=b41c21405383f, content=质量检查快一个月了，只有我是这样吗，哭死, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c558548408, createdName=ms5000001956621569, createdTime=Fri Jun 02 21:43:26 CST 2023, time=2023-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170591, encodeId=e64321e059198, content=审稿速度:6.0<br>偏重的研究方向：呼吸科;队列研究;临床<br>经验分享：速度偏慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/CPZXS1oic8FNDveZPW5MibyMJSdA1refksJRlAvOE7yHvVpVq5qlsPeHJVZDn0s8Xe1FcZAnqAwBkibf2GzHmrib4g/132, createdBy=3d292264400, createdName=hstb, createdTime=Thu Nov 23 20:28:04 CST 2023, time=2023-11-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2166518, encodeId=88322166518d8, content=审稿速度:4.0 | 投稿命中率:75.0<br>偏重的研究方向：肺肿瘤<br>经验分享：省了半年 前面一直找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1468375409, createdName=ms2000001878750293, createdTime=Fri Nov 03 16:21:43 CST 2023, time=2023-11-03, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2159829, encodeId=61162159829a0, content=ss, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=de4b5235057, createdName=147ab6f6m58(暂无昵称), createdTime=Tue Sep 26 16:07:47 CST 2023, time=2023-09-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2157853, encodeId=6391215e85305, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：呼吸科<br>经验分享：2023年4.21投稿，6.16大修，7.12修回，8.11小修，9.8录用，9.13 proof 现在正在交版面费阶段, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1efa8537263, createdName=ms3000000776207476, createdTime=Fri Sep 15 16:10:20 CST 2023, time=2023-09-15, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2123633, encodeId=682e212363326, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：肺癌<br>经验分享：2022年10月15日转投，1月8号大修，然后1月29修回，3月22小修（格式问题），3月23修回，4月3accept。总体速度可以，一审时间有点久，当初发邮件给编辑部问了一下。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08cd5169632, createdName=146d3b97m12(暂无昵称), createdTime=Tue Apr 04 10:28:17 CST 2023, time=2023-04-04, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2139285, encodeId=7c8b21392850b, content=审稿速度:1.0<br>偏重的研究方向：队列研究;肺结核<br>经验分享：想问下有最近接收的嘛？现在显示Peer review, Editor Invited 两个状态??是还没有编辑愿意接手嘛？这个状态一般要持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc885635200, createdName=ms5000001401005050, createdTime=Fri May 26 21:25:04 CST 2023, time=2023-05-26, status=1, ipAttribution=山东省)]
    2023-09-15 ms3000000776207476 来自黑龙江省

    审稿速度:3.0 | 投稿命中率:75.0
    偏重的研究方向：呼吸科
    经验分享：2023年4.21投稿，6.16大修，7.12修回，8.11小修，9.8录用，9.13 proof 现在正在交版面费阶段

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2206072, encodeId=a71b22060e24d, content=审稿速度:12.0 | 投稿命中率:75.0<br>偏重的研究方向：呼吸科<br>经验分享：投稿九个月没意见，无奈了，催了好多次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/09/90c43e208f90c98f3386f19b2dc3d3b7.jpg, createdBy=a1962178299, createdName=爱爬树的松鼠, createdTime=Wed May 22 19:10:42 CST 2024, time=17小时前, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090674, encodeId=461e20906e471, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：肺疾病;肿瘤;肺肿瘤<br>经验分享：6.12 First submitted 6.15 Editor invited 6.25 Reviewers invited 7.3 Reviews received 8.9 Major revision 8.19 Submitted 9.8 Reviewers invited 9.20 Major revision 9.27 Accepted 三个月时间，大修了两次，因为条件原因无法补实验，但是最终还是接收了，编辑真的很不错！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80638145994, createdName=ms6000001354647172, createdTime=Tue Sep 27 18:27:07 CST 2022, time=2022-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167979, encodeId=d3e1216e979a7, content=Editor Invited 已经一个多月了啊，怎么搞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e486569012, createdName=ms8000000465818220, createdTime=Sat Nov 11 15:02:18 CST 2023, time=2023-11-11, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2140538, encodeId=b41c21405383f, content=质量检查快一个月了，只有我是这样吗，哭死, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c558548408, createdName=ms5000001956621569, createdTime=Fri Jun 02 21:43:26 CST 2023, time=2023-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170591, encodeId=e64321e059198, content=审稿速度:6.0<br>偏重的研究方向：呼吸科;队列研究;临床<br>经验分享：速度偏慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/CPZXS1oic8FNDveZPW5MibyMJSdA1refksJRlAvOE7yHvVpVq5qlsPeHJVZDn0s8Xe1FcZAnqAwBkibf2GzHmrib4g/132, createdBy=3d292264400, createdName=hstb, createdTime=Thu Nov 23 20:28:04 CST 2023, time=2023-11-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2166518, encodeId=88322166518d8, content=审稿速度:4.0 | 投稿命中率:75.0<br>偏重的研究方向：肺肿瘤<br>经验分享：省了半年 前面一直找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1468375409, createdName=ms2000001878750293, createdTime=Fri Nov 03 16:21:43 CST 2023, time=2023-11-03, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2159829, encodeId=61162159829a0, content=ss, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=de4b5235057, createdName=147ab6f6m58(暂无昵称), createdTime=Tue Sep 26 16:07:47 CST 2023, time=2023-09-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2157853, encodeId=6391215e85305, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：呼吸科<br>经验分享：2023年4.21投稿，6.16大修，7.12修回，8.11小修，9.8录用，9.13 proof 现在正在交版面费阶段, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1efa8537263, createdName=ms3000000776207476, createdTime=Fri Sep 15 16:10:20 CST 2023, time=2023-09-15, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2123633, encodeId=682e212363326, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：肺癌<br>经验分享：2022年10月15日转投，1月8号大修，然后1月29修回，3月22小修（格式问题），3月23修回，4月3accept。总体速度可以，一审时间有点久，当初发邮件给编辑部问了一下。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08cd5169632, createdName=146d3b97m12(暂无昵称), createdTime=Tue Apr 04 10:28:17 CST 2023, time=2023-04-04, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2139285, encodeId=7c8b21392850b, content=审稿速度:1.0<br>偏重的研究方向：队列研究;肺结核<br>经验分享：想问下有最近接收的嘛？现在显示Peer review, Editor Invited 两个状态??是还没有编辑愿意接手嘛？这个状态一般要持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc885635200, createdName=ms5000001401005050, createdTime=Fri May 26 21:25:04 CST 2023, time=2023-05-26, status=1, ipAttribution=山东省)]
    2023-04-04 146d3b97m12(暂无昵称) 来自陕西省

    审稿速度:3.0 | 投稿命中率:50.0
    偏重的研究方向：肺癌
    经验分享：2022年10月15日转投，1月8号大修，然后1月29修回，3月22小修（格式问题），3月23修回，4月3accept。总体速度可以，一审时间有点久，当初发邮件给编辑部问了一下。

    4

    展开4条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2206072, encodeId=a71b22060e24d, content=审稿速度:12.0 | 投稿命中率:75.0<br>偏重的研究方向：呼吸科<br>经验分享：投稿九个月没意见，无奈了，催了好多次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/09/90c43e208f90c98f3386f19b2dc3d3b7.jpg, createdBy=a1962178299, createdName=爱爬树的松鼠, createdTime=Wed May 22 19:10:42 CST 2024, time=17小时前, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090674, encodeId=461e20906e471, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：肺疾病;肿瘤;肺肿瘤<br>经验分享：6.12 First submitted 6.15 Editor invited 6.25 Reviewers invited 7.3 Reviews received 8.9 Major revision 8.19 Submitted 9.8 Reviewers invited 9.20 Major revision 9.27 Accepted 三个月时间，大修了两次，因为条件原因无法补实验，但是最终还是接收了，编辑真的很不错！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80638145994, createdName=ms6000001354647172, createdTime=Tue Sep 27 18:27:07 CST 2022, time=2022-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167979, encodeId=d3e1216e979a7, content=Editor Invited 已经一个多月了啊，怎么搞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e486569012, createdName=ms8000000465818220, createdTime=Sat Nov 11 15:02:18 CST 2023, time=2023-11-11, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2140538, encodeId=b41c21405383f, content=质量检查快一个月了，只有我是这样吗，哭死, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c558548408, createdName=ms5000001956621569, createdTime=Fri Jun 02 21:43:26 CST 2023, time=2023-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170591, encodeId=e64321e059198, content=审稿速度:6.0<br>偏重的研究方向：呼吸科;队列研究;临床<br>经验分享：速度偏慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/CPZXS1oic8FNDveZPW5MibyMJSdA1refksJRlAvOE7yHvVpVq5qlsPeHJVZDn0s8Xe1FcZAnqAwBkibf2GzHmrib4g/132, createdBy=3d292264400, createdName=hstb, createdTime=Thu Nov 23 20:28:04 CST 2023, time=2023-11-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2166518, encodeId=88322166518d8, content=审稿速度:4.0 | 投稿命中率:75.0<br>偏重的研究方向：肺肿瘤<br>经验分享：省了半年 前面一直找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1468375409, createdName=ms2000001878750293, createdTime=Fri Nov 03 16:21:43 CST 2023, time=2023-11-03, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2159829, encodeId=61162159829a0, content=ss, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=de4b5235057, createdName=147ab6f6m58(暂无昵称), createdTime=Tue Sep 26 16:07:47 CST 2023, time=2023-09-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2157853, encodeId=6391215e85305, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：呼吸科<br>经验分享：2023年4.21投稿，6.16大修，7.12修回，8.11小修，9.8录用，9.13 proof 现在正在交版面费阶段, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1efa8537263, createdName=ms3000000776207476, createdTime=Fri Sep 15 16:10:20 CST 2023, time=2023-09-15, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2123633, encodeId=682e212363326, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：肺癌<br>经验分享：2022年10月15日转投，1月8号大修，然后1月29修回，3月22小修（格式问题），3月23修回，4月3accept。总体速度可以，一审时间有点久，当初发邮件给编辑部问了一下。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08cd5169632, createdName=146d3b97m12(暂无昵称), createdTime=Tue Apr 04 10:28:17 CST 2023, time=2023-04-04, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2139285, encodeId=7c8b21392850b, content=审稿速度:1.0<br>偏重的研究方向：队列研究;肺结核<br>经验分享：想问下有最近接收的嘛？现在显示Peer review, Editor Invited 两个状态??是还没有编辑愿意接手嘛？这个状态一般要持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc885635200, createdName=ms5000001401005050, createdTime=Fri May 26 21:25:04 CST 2023, time=2023-05-26, status=1, ipAttribution=山东省)]
    2023-05-26 ms5000001401005050 来自山东省

    审稿速度:1.0
    偏重的研究方向：队列研究;肺结核
    经验分享：想问下有最近接收的嘛？现在显示Peer review, Editor Invited 两个状态??是还没有编辑愿意接手嘛？这个状态一般要持续多久啊？

    2

    展开2条回复
共190条页码: 1/19页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分